EMMESSAR CHM Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EMMESSAR CHM Quarterly Results    (EMCH)

Here are the latest quarterly results of EMMESSAR CHM. For more details, see the EMMESSAR CHM financial fact sheet and EMMESSAR CHM share price and chart.

Excel Export | Annual Financial Info | Result Scoreboard

EMMESSAR CHM Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m191693111145 
Other income Rs m44442454 
Turnover Rs m22410125141649 
Expenses Rs m1827104101235 
Gross profit Rs m1-2-1-4-21-110 
Depreciation Rs m00000000 
Interest Rs m00000000 
Profit before tax Rs m422-105513 
Tax Rs m00000008 
Profit after tax Rs m422-10555 
Gross profit margin %3.2-301.8-21.8-50.0-53.19.2-6.821.6 
Effective tax rate %0.00.00.023.325.00.00.061.1 
Net profit margin %21.2300.040.2-6.56.242.440.811.4 
Diluted EPS Rs 0.8 0.3 0.5 -0.1 0.0 0.9 0.9 1.0  
Diluted EPS (TTM) Rs NA NA 1.9 1.5 0.7 1.3 1.7 2.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   CHD CHEMICALS  ASHOK-ALCO  STANDARD SURFACTANTS  ELANTAS BECK  ARVEE LABS  

Compare EMMESSAR CHM With:   CHD CHEMICALS  ASHOK-ALCO  STANDARD SURFACTANTS  ELANTAS BECK  ARVEE LABS  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Tatva Chintan Pharma IPO: Key Points to Consider (Views On News)

Jul 13, 2021

Should you apply for Tatva Chintan Pharma's IPO given the promising outlook for chemical sector?

India Pesticides Makes a Strong Debut. Lists at 22% Premium Over Issue Price (Views On News)

Jul 5, 2021

The IPO of India Pesticides was subscribed 29 times.

Clean Science and Technology IPO: Key Points to Consider (Views On News)

Jul 5, 2021

Clean Science and Technology shares are trading at an impressive grey market premium of 50%.

India Pesticides IPO Opens 23 June: Key Points to Know (Views On News)

Jun 21, 2021

All you need to know about India Pesticides IPO.

UPL Q4 Net Profit Up 74%: What Does It Mean for Investors? (Views On News)

May 13, 2021

Shares of UPL touched its 52-week high of Rs 703 per share, ahead of Q4 results.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

EMMESSAR CHM SHARE PRICE


Jul 23, 2021 (Close)

TRACK EMMESSAR CHM

  • Track your investment in EMMESSAR CHM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON EMMESSAR CHM

EMMESSAR CHM - KILITCH DRUGS COMPARISON

COMPARE EMMESSAR CHM WITH

MARKET STATS